Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-007614

EVP & Chief Medical Officer acquired 14,167 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rangwala Reshma · EVP & Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-24 Grant or award : show line 1 in the form +14,167 172,397 D
Loading xslF345X05/ownership.xml…